Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

Value in Health ◽

10.1016/j.jval.2014.08.107 ◽

2014 ◽

Vol 17 (7) ◽

pp. A735 ◽

Author(s):

Nguyen TTC ◽

Nguyen TTT

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Trastuzumab Therapy ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada

Journal of Medical Economics ◽

10.3111/13696998.2014.979938 ◽

2014 ◽

Vol 18 (3) ◽

pp. 173-188 ◽

Author(s):

C. L. Attard ◽

A. N. Pepper ◽

S. T. Brown ◽

M. F. Thompson ◽

P.-O. Thuresson ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Locally Advanced ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Trastuzumab Therapy ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2020.26.2.221 ◽

2020 ◽

Vol 26 (2) ◽

pp. 221-221

Author(s):

Phuong T. Tran ◽

Vakaramoko Diaby

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Cost-effectiveness analysis (CEA) of adjuvant trastuzumab therapy use in HER2-positive early-stage breast cancer (EBC)

Annals of Oncology ◽

10.1093/annonc/mdw377.11 ◽

2016 ◽

Vol 27 ◽

pp. vi353

Author(s):

K.I. Quintyne ◽

B. Woulfe ◽

A. Dee ◽

R. Gupta

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Cost Effectiveness Analysis ◽

Early Stage Breast Cancer ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Trastuzumab Therapy ◽

Effectiveness Analysis

Download Full-text

PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER

Value in Health ◽

10.1016/j.jval.2011.02.916 ◽

2011 ◽

Vol 14 (3) ◽

pp. A165

Author(s):

T.T.T. Nguyen ◽

R. Yagudina ◽

A.U. Kulikov

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Trastuzumab Therapy ◽

Positive Breast Cancer

Download Full-text

Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.25.10.1133 ◽

2019 ◽

Vol 25 (10) ◽

pp. 1133-1139 ◽

Author(s):

Naomi R.M. Schwartz ◽

Meghan R. Flanagan ◽

Joseph B. Babigumira ◽

Lotte M. Steuten ◽

Joshua A. Roth

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy

PharmacoEconomics ◽

10.1007/s40273-018-0634-5 ◽

2018 ◽

Vol 36 (4) ◽

pp. 505-505

Author(s):

Amir Ansaripour ◽

Carin A. Uyl-de Groot ◽

W. Ken Redekop

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Scenario Analysis ◽

Treatment Strategy ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Trastuzumab Therapy ◽

Optimal Treatment Strategy ◽

Positive Breast Cancer

Download Full-text

Cost-Effectiveness Analysis Of Neo-Adjuvant Pertuzumab Therapy In Women With Locally Advanced, Inflammatory, Or Early Her2-Positive Breast Cancer In Italy

Value in Health ◽

10.1016/j.jval.2015.09.1156 ◽

2015 ◽

Vol 18 (7) ◽

pp. A454

Author(s):

L Pradelli ◽

M Bellone ◽

S Era ◽

E Campagnoli

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Locally Advanced ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

Value in Health ◽

10.1016/j.jval.2015.09.1169 ◽

2015 ◽

Vol 18 (7) ◽

pp. A456-A457 ◽

Author(s):

C Tange ◽

S Kunisawa ◽

S Maeda ◽

K Shimozuma

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

Value in Health ◽

10.1016/j.jval.2018.11.014 ◽

2019 ◽

Vol 22 (4) ◽

pp. 408-415 ◽

Author(s):

Louis P. Garrison ◽

Joseph Babigumira ◽

Clément Tournier ◽

Hans-Peter Goertz ◽

Solomon J. Lubinga ◽

...

Keyword(s):

Breast Cancer ◽

United States ◽

Cost Effectiveness ◽

Adjuvant Treatment ◽

The United States ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text

PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIVENESS-ANALYSIS STUDIES OF TRASTUZUMAB (HERCEPTIN™) IN TREATMENT OF HER2-POSITIVE BREAST CANCER

Value in Health ◽

10.1016/s1098-3015(10)70199-6 ◽

2008 ◽

Vol 11 (3) ◽

pp. A60

Author(s):

OA Le

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Download Full-text